Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) — Cash Flow Quality Index
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Cash Flow Quality Index of 4.38x as of December 2025. Operating cash flow of CN¥837.18 Million exceeds net income of CN¥191.35 Million, indicating high earnings quality where cash backs reported profits. Explore Anhui Huaren Health Pharmaceutical Co. L (301408) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Anhui Huaren Health Pharmaceutical Co. L cash flow conversion.
Annual Cash Flow Quality Index for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Year-by-year earnings quality comparison for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.38x | CN¥837.18 Million | CN¥191.35 Million | ▲ +5.4% |
| 2024 | 4.15x | CN¥571.76 Million | CN¥137.70 Million | ▲ +262.4% |
| 2023 | 1.15x | CN¥131.37 Million | CN¥114.67 Million | ▲ +6.0% |
| 2022 | 1.08x | CN¥173.84 Million | CN¥160.78 Million | ▼ -46.5% |
| 2021 | 2.02x | CN¥140.82 Million | CN¥69.73 Million | — |